Immunotherapy Toxicities: Checkpoint Inhibitors 0.75 CE
Immunotherapy Toxicities: Checkpoint Inhibitors
At the end of the presentation the learner will be able to:
- Define the function of the immune system
- Describe the type, mechanism of action, and indication for immunotherapy
- Identify common and rare toxicities associated with checkpoint inhibitors
- Recall methods of patient education surrounding immunotherapy toxicities
Amy DiMaggio, MSN, RN, CMSRN, OCN
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.
- 0.75 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation